The Immune Response Corporation Injects First Patient in Trial of ...
PharmaLive.com (press release) - Newtown,PA,USA
NeuroVax(TM) may represent a significant advance in the treatment of MS, which affects more than 2.5 million people worldwide, including more than 400000 in ...
See all stories on this topic